Beigene Stock In The News

BGNE Stock  USD 190.30  0.21  0.11%   
Our overall analysis of BeiGene's news coverage and content from conventional and social sources shows investors' bearish mood towards BeiGene. The specific impact of BeiGene news on its stock price will depend on a range of factors, including the nature and significance of the news report and investors' perceptions of BeiGene's overall financial health and prospects. It also depends on the type and quality of a news publisher.
  
Some academic researchers believe in a strong correlation between financial news and their impacts on the movements of stock prices. Macroaxis does not take a position on this subject and only provides tools that can help investors to time the market using BeiGene headlines in addition to utilizing other, more conventional financial analysis modules. Check out BeiGene Backtesting and BeiGene Hype Analysis.
For information on how to trade BeiGene Stock refer to our How to Trade BeiGene Stock guide.

BeiGene Today Top News and Investor Outlook

Yahoo News
BeiGene Receives Positive CHMP Opinions ...
https://finance.yahoo.com/news/beigene-receives-positive-chmp-opinions-100000607.html
 Neutral
Yahoo News
Recent 7.2% pullback isn't enough to hurt long-term BeiGene (NASDAQ:BGNE) shareholders, they're still up 60% over 5 years
https://finance.yahoo.com/news/recent-7-2-pullback-isnt-191633891.html
 Bullish
Yahoo News
BeiGene Highlights Waldenström’s Macroglobulinemia Innovation at IWWM 2024
https://finance.yahoo.com/news/beigene-highlights-waldenstr-m-macroglobulinemia-100000341.html
 Neutral
Yahoo News
Here’s Why BeiGene, Ltd. (BGNE) Rallied in Q3
https://finance.yahoo.com/news/why-beigene-ltd-bgne-rallied-140952567.html
 Bullish
Yahoo News
BeiGene (BGNE) Moves 5.3% Higher: Will This Strength Last?
https://finance.yahoo.com/news/beigene-bgne-moves-5-3-090400520.html
 Bullish
Yahoo News
3 Stocks That May Be Trading Below Intrinsic Value By Up To 48.2%
https://finance.yahoo.com/news/3-stocks-may-trading-below-130658318.html
 Bullish
Yahoo News
BeiGene Provides Update on FDA Advisory ...
https://finance.yahoo.com/news/beigene-provides-fda-advisory-committee-222100418.html
 Neutral
Yahoo News
Global Oncology Innovator BeiGene Appoints Shalini Sharp to Board of Directors
https://finance.yahoo.com/news/global-oncology-innovator-beigene-appoints-100000312.html
 Bullish
Yahoo News
FDA Casts Doubt On Use Of Merck, Bristol Myers' PD-1 Cancer Drugs For Certain Type Of Gastric Cancer Patients
https://finance.yahoo.com/news/fda-casts-doubt-merck-bristol-195439409.html
 Neutral
Yahoo News
High Growth Tech Stocks To Watch In September 2024
https://finance.yahoo.com/news/high-growth-tech-stocks-watch-140255259.html
 Bullish

BeiGene Past News Timeline

Popular news outlets such as MarketWatch, Bloomberg, or Reuters provide BeiGene and other traded companies coverage with news coverage. We help investors stay connected with BeiGene headlines for the 25th of November to make an informed investment decision based on correlating the impacts of news items on BeiGene Stock performance. Please note that trading solely based on the BeiGene hype is not for everyone as timely availability and quick action are needed to avoid losses.
BeiGene's linear event process diagram shows some of the filtered current and past headlines as well as many other corporate-specific events such as SEC filings, dividends, and regulatory reporting available to the public. This module can help BeiGene investors visualize upcoming and past events in order to time the market based on BeiGene noise-free hype analysis.
BeiGene stock price changes are notoriously difficult to predict based exclusively on its news coverage or social hype. Still, the BeiGene earnings-per-share ratio is a good starting point for gauging a company's future prospects. If a firm's EPS rises and meets or even beats consensus forecasts, its shares stand to increase. However, some very sophisticated investors can spot management manipulation of EPS through actions such as buybacks.
Far too much social signal, news, headlines, and media speculation about BeiGene that are available to investors today. That information is available publicly through BeiGene media outlets and privately through word of mouth or via BeiGene internal channels. However, regardless of the origin, that massive amount of BeiGene data is challenging to quantify into actionable patterns, especially for investors that are not very sophisticated with ever-evolving tools and techniques used in the investment management field.
A primary focus of BeiGene news analysis is to determine if its current price reflects all relevant headlines and social signals impacting the current market conditions. A news analyst typically looks at the history of BeiGene relative headlines and hype rather than examining external drivers such as technical or fundamental data. It is believed that price action tends to repeat itself due to investors' collective, patterned thinking related to BeiGene's headlines and news coverage data. This data is often completely overlooked or insufficiently analyzed for actionable insights to drive BeiGene alpha.

BeiGene Largest EPS Surprises

Earnings surprises can significantly impact BeiGene's stock price both in the short term and over time. Negative earnings surprises usually result in a price decline. However, it has been seen that positive earnings surprises lead to an immediate rise in a stock's price and a gradual increase over time. This is why we often hear news about some companies beating earning projections. Financial analysts spend a large amount of time predicting earnings per share (EPS) along with other important future indicators. Many analysts use forecasting models, management guidance, and additional fundamental information to derive an EPS estimate.
Reported
Fiscal Date
Estimated EPS
Reported EPS
Surprise
2017-03-22
2016-12-31-0.89-1.05-0.1617 
2016-11-10
2016-09-30-0.82-1.08-0.2631 
2017-08-09
2017-06-30-1.25-1.52-0.2721 
2018-05-09
2018-03-31-1.7-2.03-0.3319 
2016-05-11
2016-03-31-0.63-0.97-0.3453 
2017-05-10
2017-03-31-0.92-1.27-0.3538 
View All Earnings Estimates

BeiGene Stock Latest Headlines

Some academic researchers believe in a strong correlation between financial news and their impacts on the movements of stock prices. Macroaxis does not take a position on this subject and only provides tools that can help investors to time the market using conventional financial analysis. Below is the latest headlines and news related to BeiGene Stock. Current markets are strongly bullish. About 75% of major world exchanges and indexes are currently up. See today's market update for more information.
Gurufocus Stories at Macroaxis
19th of November 2024
BeiGene Sees Pre-Market Rise with Strong Q3 Sales Growth
at gurufocus.com 
businesswire News
15th of November 2024
BeiGene revela proposta de mudana de nome para BeOne Medicines, reafirmando sua misso de u...
at businesswire.com 
businesswire News
14th of November 2024
BeiGene Unveils Proposed Name Change to BeOne Medicines, Reaffirming Its Mission to Unite ...
at businesswire.com 
Gurufocus Stories at Macroaxis
13th of November 2024
BeiGene Ltd Q3 2024 Earnings EPS of , Revenue Surpasses Estimates at 1.002 Billion
at gurufocus.com 
Gurufocus Stories at Macroaxis
8th of November 2024
BeiGene Shares Rise as ASH Conference Highlights Key Developments
at gurufocus.com 
businesswire News
28th of October 2024
BeiGeneDonald Glazer
at businesswire.com 
businesswire News
21st of October 2024
BeiGene Receives Positive CHMP Opinions for TEVIMBRA as a First-Line Treatment for Advance...
at businesswire.com 

Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards BeiGene in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, BeiGene's short interest history, or implied volatility extrapolated from BeiGene options trading.
When determining whether BeiGene is a strong investment it is important to analyze BeiGene's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact BeiGene's future performance. For an informed investment choice regarding BeiGene Stock, refer to the following important reports:
Check out BeiGene Backtesting and BeiGene Hype Analysis.
For information on how to trade BeiGene Stock refer to our How to Trade BeiGene Stock guide.
You can also try the FinTech Suite module to use AI to screen and filter profitable investment opportunities.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of BeiGene. If investors know BeiGene will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about BeiGene listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(8.19)
Revenue Per Share
225.239
Quarterly Revenue Growth
0.395
Return On Assets
(0.1)
Return On Equity
(0.23)
The market value of BeiGene is measured differently than its book value, which is the value of BeiGene that is recorded on the company's balance sheet. Investors also form their own opinion of BeiGene's value that differs from its market value or its book value, called intrinsic value, which is BeiGene's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because BeiGene's market value can be influenced by many factors that don't directly affect BeiGene's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between BeiGene's value and its price as these two are different measures arrived at by different means. Investors typically determine if BeiGene is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, BeiGene's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.